Editorial Comment on: Defining Early Morbidity of Radical Cystectomy for Patients with Bladder Cancer Using a Standardized Reporting Methodology

European Urology

Volumn 55, Issue 1, 2009, Pages 175-176

  Colombo, Renzo ^a  

^a VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BLADDER CANCER; BLADDER SURGERY; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER SURGERY; CYSTECTOMY; DISEASE SEVERITY; GASTROINTESTINAL SYMPTOM; HUMAN; MEDICAL LITERATURE; METHODOLOGY; MORBIDITY; OUTCOME ASSESSMENT; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; STANDARDIZATION; SURGICAL TECHNIQUE; URINARY DIVERSION;

CYSTECTOMY; FEMALE; HUMANS; MALE; URINARY BLADDER NEOPLASMS;

EID: 56249091047     PISSN: 03022838     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eururo.2008.07.033     Document Type: Note

References (8)

1. David K.A., Milowsky M.I., Ritchey J., Carroll P.R., and Nanus D.M. Low incidence of perioperative chemotherapy for stage III bladder cancer 1998 to 2003: a report from the National Cancer Data Base. J Urol 178 (2007) 451-454
2. Muramaki M., Miyake, Kurahashi T., Takenaka A., Inoue T.A., and Fujisawa M. Prognostic significance of adjuvant cisplatin-based combination chemotherapy following radical cystectomy in patients with invasive bladder cancer. Int J Urol 15 (2008) 314-318
3. Izawa J.I., Chin J.L., and Winquist E. Timing cystectomy and perioperative chemotherapy in the treatment of muscle-invasive bladder cancer. Can J Urol 13 (2006) 48-53
4. Rosenberg J.E. Current status of neoadjuvant and adjuvant chemotherapy for muscle-invasive bladder cancer. Expert Rev Anticancer Ther 7 (2007) 1729-1736
5. Donat S.M., Shabsigh A., Savage C., et al. Potential impact of postoperative early complications on the timing of adjuvant chemotherapy in patients undergoing radical cystectomy: a high-volume tertiary cancer center experience. Eur Urol 55 (2009) 177-186
6. Raghavan K., Quinn D., Skinner D.G., and Stein J.P. Surgery and adjunctive chemotherapy for invasive bladder cancer. Surg Oncol 11 (2002) 55-63
7. Gofrit ON, Stadler WM, Zorn KC, et al. Adjuvant chemotherapy in lymph node positive bladder cancer. Urol Oncol. In press. doi:10.1016/j.urolonc.2007.12.013.
8. Shabsigh A., Korets R., Vora K.C., et al. Defining early morbidity of radical cystectomy for patients with bladder cancer using a standardized reporting methodology. Eur Urol 55 (2009) 164-176